Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2005
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome
J A Ajani, P F Mansfield, C H Crane, et al.
Human Mutation
|
January 1, 1997
Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas
J Yin, D Kong, S Wang, et al.
Cancer
|
July 24, 2001
A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction
J A Ajani, R Komaki, J B Putnam, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 6, 1999
Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer
N A Janjan, J Abbruzzese, R Pazdur, et al.
Gut
|
May 16, 2002
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis
R K S Phillips, M H Wallace, P M Lynch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2018
Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2
K Chang, J A Willis, J Reumers, et al.
Annals of Internal Medicine
|
July 27, 1999
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial
G Steinbach, R Ford, G Glober, et al.
The New England Journal of Medicine
|
June 30, 2000
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
G Steinbach, P M Lynch, R K Phillips, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2005
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome
J A Ajani, P F Mansfield, C H Crane, et al.
Human Mutation
|
January 1, 1997
Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas
J Yin, D Kong, S Wang, et al.
Cancer
|
July 24, 2001
A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction
J A Ajani, R Komaki, J B Putnam, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 6, 1999
Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer
N A Janjan, J Abbruzzese, R Pazdur, et al.
Gut
|
May 16, 2002
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis
R K S Phillips, M H Wallace, P M Lynch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2018
Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2
K Chang, J A Willis, J Reumers, et al.
Annals of Internal Medicine
|
July 27, 1999
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial
G Steinbach, R Ford, G Glober, et al.
The New England Journal of Medicine
|
June 30, 2000
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
G Steinbach, P M Lynch, R K Phillips, et al.
Page
of 7